3did: identification and classification of domain-based interactions of known three-dimensional structure by Stein, Amelie et al.
3did: identification and classification of
domain-based interactions of known
three-dimensional structure
Amelie Stein
1, Arnaud Ce ´ol
1 and Patrick Aloy
1,2,*
1Institute for Research in Biomedicine (IRB), Join IRB-BSC Program in Computational Biology, c/Baldiri Reixac
10–12, 08028 Barcelona and
2Institucio ´ Catalana de Recerca i Estudis Avanc ¸ats (ICREA), Passeig Lluı ´s
Companys, 23, 08010 Barcelona, Spain
Received September 9, 2010; Accepted September 30, 2010
ABSTRACT
The database of three-dimensional interacting
domains (3did) is a collection of protein interactions
for which high-resolution three-dimensional struc-
tures are known. 3did exploits the availability of
structural data to provide molecular details on inter-
actions between two globular domains as well as
novel domain–peptide interactions, derived using a
recently published method from our lab. The inter-
face residues are presented for each interaction
type individually, plus global domain interfaces at
which one or more partners (domains or peptides)
bind. The 3did web server at http://3did
.irbbarcelona.org visualizes these interfaces along
with atomic details of individual interactions using
Jmol. The complete contents are also available for
download.
INTRODUCTION
Proteins are key players in virtually all biological events
that take place within and between cells. Yet proteins
seldom act in isolation and often accomplish their
function as part of large molecular machines, whose
action is coordinated through intricate regulatory
networks of transient protein–protein interactions. It is
thus the connections between molecules, rather than the
individual components, that will ultimately determine the
behaviour of a biological system. Consequently, large re-
sources have been devoted to unveiling protein interrela-
tionships in a high-throughput manner, and the last years
have seen the consecution of the ﬁrst interactome drafts
for several model organisms, including human (1–3).
However, high-throughput interaction discovery experi-
ments can only indicate that two proteins interact, but
do not reveal the molecular details or the mechanism of
binding. Currently, this atomic level of detail is only
captured in high-resolution three-dimensional (3D) struc-
tures, in which individual residue contacts are resolved
and the protein interaction interfaces characterized.
Efforts to gather and classify such molecular details of
interacting structures initially focused on domain–
domain interfaces (4,5), while in recent years databases
containing structures of more elusive peptide-mediated
interactions have been created (6–10).
The database of 3D interacting domains (3did) provides
a collection of domain-based interactions for which a
high-resolution 3D structure is available. We analysed
all interacting structures in the Protein Data Bank
(PDB) (11) involving one or more globular domains,
and classiﬁed them into two main categories on the basis
of their contact interfaces: domain–domain and domain–
peptide interactions (12). It is worth noting that both
classes of interactions can mediate binding between differ-
ent proteins, but also form intramolecular interactions.
Based on the observation that homologous pairs of
binding proteins tend to use the same interaction
topology (13), we have classiﬁed the interactions in 3did
by their interface residues. This allows us to provide topo-
logical information for each ‘Interaction Type’ (14) as well
as global interface regions for each domain by considering
all binding partners simultaneously. Where available,
we also provide GO terms for the globular domains in
3did (15).
DOMAIN–DOMAIN INTERACTIONS
Globular domains can fold and interact independently
from other elements in the same protein and thus consti-
tute ideal modules to drive functional associations of
proteins, such as those between different cyclins and
CDKs during cell cycle progression (16). Domain–
domain interactions form a relatively large and stable
interface of 2.000A ˚ 2 on average (17). We identiﬁed all
cases of domain–domain interactions of known 3D struc-
ture by ﬁrst assigning Pfam (18) domains to each
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Next we computed atomic contacts between domains in
the same structure, requiring at least ﬁve contacts
(hydrogen bonds, electrostatic or van der Waals inter-
actions) to avoid artifacts (non-functional associations)
from crystal packing, and removed those lacking a signiﬁ-
cant interface as described in (19,20). At the moment,
there are 159557 3D structures of domain–domain inter-
actions (DDIs) in 3did, involving 161996 proteins. These
DDIs cover 4186 distinct domains, around a third of the
total number of domains in Pfam, forming 5971 different
domain pairs between them. The vast majority of these,
4218 DDIs, are always found to mediate binding between
different proteins (intermolecular interactions), while 827
are only observed in intramolecular interactions, and 926
additional pairs are found both inter- and intramolecular.
It is interesting to note that, in the last two years, the
number of unique domain–domain interactions has
increased by 20%, thus considerably augmenting the
structural coverage of the interaction space.
PEPTIDE-MEDIATED INTERACTIONS
Domain-peptide, or peptide-mediated, interactions occur
when a globular domain in one protein recognizes a short
linear peptide from another, creating a relatively small
interface of 350A ˚ 2 on average [according to Stein and
Aloy (21)]. This kind of interaction is frequently found in
signal transduction networks and sometimes requires
dynamic switches like phosphorylation or other
post-translational modiﬁcations for binding to their rec-
ognition domain (22,23). Due to their transient nature,
peptide-mediated interactions are more difﬁcult to
handle biochemically and thus under-represented in struc-
tural databases. The linear motifs that characterize the
binding peptide are short patterns of around 10 residues
with a common function (i.e. binding to a globular
domain) that occur in otherwise unrelated proteins.
Despite their shortness, the motifs alone bind their
target proteins with sufﬁcient strength to establish a func-
tional interaction (24), while the ﬂanking residues are
crucial for speciﬁcity (21). Linear motifs are frequently
found in disordered or unstructured regions and adopt a
well-deﬁned structure only upon binding. In fact, we have
exploited this feature to discover ‘hidden’ peptide-
mediated interactions among all known 3D structures
(see below). A well-studied example of a peptide-mediated
interactions occurs between the Src-homology-3 (SH3)
domain and proline-rich peptides; [RKY]xxPxxP or
PxxPx[KR] are two typical patterns recognized by SH3
domains, where x indicates arbitrary residues and square
brackets allow any of the enclosed residues. Much of what
is currently known about peptide-mediated interactions is
compiled in the Eukaryotic Linear Motif (ELM) database
(25), which provides a literature-curated collection of
motifs and their interaction partners. In 2008, we pub-
lished a set of 829 manually curated peptide-mediated
interactions in 3D structures matching the patterns in
ELM (21), and included these interactions in 3did (7).
During the manual curation of these interacting
structures, we observed that peptides bound to their rec-
ognition domain tend to be more ﬂat and elongated than
other peptides of the same length (Figure 1). Based on this
characteristic, we created a method to automatically
identify peptide-mediated interactions in high-resolution
3D structures, which successfully recognizes known cases
as well as novel peptide-binding domains (26). In brief, the
method ﬁrst identiﬁes candidate peptide-domain inter-
actions based on structural features, then these are clus-
tered by interaction topology, and patterns are derived for
all clusters with sufﬁcient (non-redundant) information.
As an additional validation, we tested whether the
derived peptides and their binding domains are signiﬁ-
cantly over-represented in the current interactomes of
human, ﬂy, worm or yeast (26). Only those network-
over-represented validated cases are now included in
3did. Due to the automated nature of this method, it
will be possible to perform regular updates of the collec-
tion of peptide-mediated interactions in 3D structures.
Currently, 3did contains 2345 instances of peptide-
mediated interactions, involving 1748 protein pairs,
63 Pfam domains and 114 linear motifs either stemming
from ELM or derived using the detection method outlined
above. This represents roughly a 3-fold increase in the
number of peptide-mediated interactions with respect to
previous versions of 3did.
IDENTIFICATION OF INTERACTION INTERFACES
Studying the structures of homologous pairs of interacting
proteins has revealed that they very often have the same
binding topology (14), although there are exceptions (27).
Based on this observation, we have identiﬁed and grouped
the residues involved in binding interfaces for each
domain. In order to get a reference that is stable across
the addition of new instances, we aligned all sequences to
Figure 1. Flat and elongated nature of bound peptides. The chromatin
assembly factor 1 peptide [magenta, PDB:1s4z (32)], bound to a
chromo shadow domain in HP1beta, illustrates the typical ﬂat and
elongated structure that many peptides assume upon binding to their
recognition domain. We have recently exploited this feature, together
with other structural properties of peptide-mediated interactions, to
identify ‘hidden’ cases of such binding events in the PDB (26).
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proﬁles involved in the interactions. Then we clustered the
interfaces by the fraction of shared residues as described
before (7,26); similar clustering procedures have been im-
plemented for other datasets of interacting protein struc-
tures (28,29). As these interaction interfaces are computed
for each domain, a domain–domain ‘Interaction
Topology’ is classiﬁed by the combination of the two
interfaces involved. For example, the most common
topology for the interaction between Ras and RhoGEF
is 0:2, i.e. interface 0 for Ras and interface 2 for RhoGEF,
where 0 and 2 are simply identiﬁers from the clustering
procedure (Figure 2). For domain–peptide interactions,
only one topology identiﬁer is provided, as we currently
do not describe the peptide side of the interface. It should
also be noted that not all contacting residues necessarily
lie in the HMM proﬁle. In fact, occasionally, none of them
does, and in those (rare) cases no interface residues are
captured by our method. This implies that the interface
positions are not conserved. Interestingly, we ﬁnd only
such interfaces currently in domain–peptide interactions,
indicating a lower conservation of these binding sites.
According to our current data, the notion still holds that
the majority of interaction types always show the same
topology (Figure 3). However, for cases with multiple
functional interaction topologies it is important to
consider these possibilities in applications like homology
modelling.
In addition to the individual interfaces for each inter-
action type, we have now introduced global interface
clusters for each domain. These group binding partners
use the same, or largely overlapping, interaction surfaces
of a given domain, and may thus help identify positions
which are crucial for binding multiple partners. This is
especially important for proteins like Ras, which have
many binding partners with overlapping interfaces
(13,30). The global interfaces are computed via complete
linkage hierarchical clustering (31) over the fractions of
overlapping positions in all individual interaction-
type-interfaces for this domain. Cases with a minimum
overlap of 25% among all partners are grouped
together. In the interface visualization of the 3did web
server, the fraction of different partners using a given
residue is indicated by the height of the corresponding
bar. At the moment, we ﬁnd multiple binding partners
for 4020 interaction interfaces on 1675 domains in 3did.
Overall, 2511 domains have only single-partner interfaces,
162 have only multi-partner interfaces and 1513 have both
types (Figure 3).
Figure 2. Domain–domain interactions with interface topologies and structure display. For the selected domain pair, 3did displays all topologies
observed in the different instances of this interaction type in all 3D structures, sorted by their frequency. Each ‘Interface Topology’ has an identiﬁer
(ID) of the form X:Y that is composed of the respective cluster IDs of the two domains. Here, the most common topology for Ras:RhoGEF is 0:2,
while all other observed topologies are much less frequent. For homomeric interactions, X:X marks a symmetric topology. The ‘rainbow’ color
scheme is used to indicate where interface residues lie in the sequence, from N-terminus (blue) to C-terminus (red), based on alignment to the HMM
proﬁle of the respective domains (see main text). The 3D structure of the selected instance is displayed using Jmol next to the topologies, while the
interaction details (PDB ID, domain positions, score, Z-score, topology ID) are listed below. Users can select the 3D structure to be shown by
clicking on the Jmol icon in the corresponding row. In domain–domain interactions, the two domains are shown in magenta and cyan, while
peptide-binding domains are shown in a rainbow colour scheme to match the interface visualization.
D720 Nucleic AcidsResearch, 2011, Vol.39, Database issue3did USAGE AND VISUALIZATION
The easiest way of searching 3did for domain-based inter-
actions is through our web interface, which can be queried
with a domain or motif name or keyword, a pair of inter-
acting or indirectly connected domains, the sequence or
PDB code of a particular protein, or GO terms of interest.
As in previous versions, 3did will then display all domains
and peptides that physically interact with the domain of
interest (or present in the selected structure or sequence)
and for which 3D data of the interaction interface is avail-
able. Interaction partners are grouped by the global
binding interfaces described above, which are visualized
in a blue-to-red rainbow colour scheme (from N- to
C-terminus). The relative height of the individual
position bars indicates the fraction of binding partners
that actually use this residue (Figure 4). If only one
binding partner is found for a given interface, all these
bars have the same height. Note that, as these interfaces
are based on Pfam HMMs, a sequence of interest needs to
be aligned to the respective HMM in order to identify the
interacting residues. All interaction partners will also be
displayed in an interactive network indicating the type of
element (domain or peptide), whether the interactions are
intra or intermolecular, and functional annotations from
GO where available. From the list of interacting domains
and peptides, the user can select individual interaction
types to access their molecular details. The domain–
domain and domain–peptide interaction pages displays
all interface topologies of the domain(s) involved in the
binding, along with the frequency of their occurrence in
the current set of 3D structures. As described above, for
domain–domain interactions the ‘Interaction Topology’ is
composed of the two interface IDs involved (cf. Figure 2).
The interaction pages also provide listings of each 3D
structure in which the selected interaction type is found,
plus detailed information on the position of the domains
and peptides in this structure. Furthermore, it provides
empirical potential scores and Z-scores for the interaction,
which indicates the number of favourable contacting
residue pairs in this interface (19,20). In general, the
higher the Z-score the more speciﬁc an interaction is.
The actual 3D structure of the interaction is displayed in
the upper right corner of the page by clicking on the Jmol
(http://www.jmol.org) icon (Figure 2). For domain–
domain interactions, the two domains are coloured
magenta and cyan and shown in ‘cartoon’ representation
with the residues participating in the interface (i.e. making
hydrogen bonds, salt bridges or van der Waals contacts)
shown as ‘sticks’. For domain–peptide interactions, the
domain is in ‘cartoon’ representation and coloured
following a ‘rainbow’ scheme that corresponds to the
HMM-proﬁle-based visualization of the interface
residues, while the peptide is shown in gray, and interact-
ing residues are again shown as ‘sticks’. For entire
PDB structures, all chains are shown in ‘cartoon’
representation.
AVAILABILITY
The 3did web server at http://3did.irbbarcelona.org allows
direct querying of the database and provides MySQL
dumps and ﬂat ﬁles containing the full dataset for
download, for users interested in large-scale studies.
Domain–domain interactions in 3did are updated weekly
to include newly released structures. Peptide-mediated
interactions will be updated in major releases, which will
occur when new Pfam versions become available.
Figure 3. Number of domain interfaces. About half of the domain–domain interactions currently stored in 3did are only observed in one interaction
topology, and only a small fraction shows ten or more different binding orientations. Similarly, roughly 50% of the domains in 3did have one or two
global binding interfaces, while few have 10 interfaces or more.
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